Zimmer Wins FDA Clearance for iASSIST
Zimmer Holdings, Inc. (NYSE: ZMH;
SIX: ZMH), a global leader in musculoskeletal health, today announced that it
has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)
to market iASSIST Knee, the Personalized Guidance System for knee
iASSIST represents a revolutionary next step in surgical guidance, providing
simple, intuitive and accurate intraoperative feedback and alignment
validation to surgeons during joint replacement procedures, eliminating the
need for bulky capital equipment. Current robotic and navigation systems use
optical-tracking, requiring a clear line-of-sight into the surgical field, and
rely upon complex additional equipment in the operating room, providing
feedback on external computer screens.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.